Column Capital Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $6.37K | Hold |
412
| – | – | ﹤0.01% | 575 |
|
|
2023
Q2 | $6.47K | Hold |
412
| – | – | ﹤0.01% | 591 |
|
|
2023
Q1 | $6.79K | Buy |
412
+305
| +285% | +$5.03K | ﹤0.01% | 607 |
|
|
2022
Q4 | $1.67K | Hold |
107
| – | – | ﹤0.01% | 716 |
|
|
2022
Q3 | $1K | Hold |
107
| – | – | ﹤0.01% | 704 |
|
|
2022
Q2 | $2K | Sell |
107
-314
| -75% | -$5.87K | ﹤0.01% | 649 |
|
|
2022
Q1 | $6K | Buy |
421
+345
| +454% | +$4.92K | ﹤0.01% | 564 |
|
|
2021
Q4 | $1K | Sell |
76
-322
| -81% | -$4.24K | ﹤0.01% | 759 |
|
|
2021
Q3 | $7K | Hold |
398
| – | – | ﹤0.01% | 514 |
|
|
2021
Q2 | $7K | Hold |
398
| – | – | ﹤0.01% | 516 |
|
|
2021
Q1 | $7K | Hold |
398
| – | – | ﹤0.01% | 508 |
|
|
2020
Q4 | $7K | Hold |
398
| – | – | ﹤0.01% | 504 |
|
|
2020
Q3 | $7K | Hold |
398
| – | – | ﹤0.01% | 499 |
|
|
2020
Q2 | $7K | Hold |
398
| – | – | ﹤0.01% | 532 |
|
|
2020
Q1 | $6K | Hold |
398
| – | – | ﹤0.01% | 479 |
|
|
2019
Q4 | $7K | Buy |
+398
| New | +$7K | ﹤0.01% | 500 |
|